Morgan Stanley Upgrades Becton Dickinson (BDX) to Overweight
More News related to BDX
- BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
- Becton, Dickinson (BDX) Boosts Qtr. Dividend by 12.1%, Authorizes 10M Share Buyback
- BD Board Increases Dividend and Authorizes Additional Share Repurchases
- Notable Mergers and Acquisitions of the Day 11/23: GMCR/DDRX, PBCT/FIF, CIEN, BDX, IDTI
- Notable Mergers and Acquisitions of the Day: MOT, BDX
More News related to Upgrades
- Shares of Brocade (BRCD) Outperforming as Oscar Gruss Upgrades to Buy
- Kinross (KGC) Jumps Higher as Gold Breaks $1,200, JPMorgan Upgrades to Overweight
- Raymond James Upgrades PSS World Medical (PSSI) to Outperform
- Capital One Southcoast Upgrades Penn Virginia (PVA) to Add; Turning Bullish After Data Release
- Raymond James Upgrades CPFL Energia S.A. (CPL) to Outperform
Morgan Stanley upgrades Becton Dickinson (NYSE: BDX) from Equal Weight to Overweight.
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.
Related Categories
UpgradesStocks Mentioned
+1.20Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
